Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer
Clinical trial NCT07535359 · AVAILABLE
Trial details
- NCT number
- NCT07535359
- Sponsor
- Daiichi Sankyo
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.